Intensifying daunorubicin in induction for patients with core binding factor leukemia.
Dobashi
Nobuaki
N
Yamaguchi
Yuko
Y
Asai
Osamu
O
Yano
Shingo
S
Osawa
Hiroshi
H
Yahagi
Yuichi
Y
Takei
Yutaka
Y
Sugiyama
Katsuki
K
Saito
Takeshi
T
Usui
Noriko
N
D000293:Adolescent; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D003630:Daunorubicin / Q000008:administration & dosage*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D015996:Survival Rate; D016896:Treatment Outcome
D000903:Antibiotics, Antineoplastic; D003630:Daunorubicin